Skip to main navigation
Skip to search
Skip to main content
Lund University Home
English
Svenska
Home
Profiles
Research output
Projects
Units
Infrastructure
Activities
Prizes and Distinction
Search by expertise, name or affiliation
A valuable pair - candidate biomarkers RBM3 and PODXL in urothelial bladder cancer
Karolina Granfelt Boman
Tumor microenvironment
Research output
:
Thesis
›
Doctoral Thesis (compilation)
539
Downloads (Pure)
Overview
Fingerprint
Research output
(2)
Fingerprint
Dive into the research topics of 'A valuable pair - candidate biomarkers RBM3 and PODXL in urothelial bladder cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Biological Marker
100%
Bladder Cancer
100%
Patient
50%
Neoadjuvant Chemotherapy
50%
Disease
37%
Protein
12%
Death
12%
Chemotherapy
12%
Gemcitabine
12%
Cystectomy
12%
Prognostic Factor
12%
Synapsin II
12%
Biochemistry, Genetics and Molecular Biology
Progression Free Survival
66%
Survival
33%
Protein
33%
Cell Membrane
33%
Cisplatin
33%
Protein Motif
33%
RNA Recognition Motif
33%
Gemcitabine
33%
Immunology and Microbiology
Prognostic Biomarker
33%
Bladder Cancer Cell Line
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
62%